Development and validation of an RNA sequencing-based classifier for medullary thyroid carcinoma on thyroid FNA
- PMID: 36047747
- PMCID: PMC10294123
- DOI: 10.1002/cncy.22643
Development and validation of an RNA sequencing-based classifier for medullary thyroid carcinoma on thyroid FNA
Conflict of interest statement
CONFLICTS OF INTEREST
The authors made no disclosures.
Comment on
- Cancer Cytopathol.
References
-
- Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol (Oxf). 1998;48:265–273. - PubMed
-
- Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139–1148. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
